Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
Clinical Genitourinary Cancer|September 17, 2024
Rare type of Bellini Duct Carcinoma in a Patient With Cacchi-Ricci Disease: A Case Report and Mini-ReviewAntonio Franco, Thomas Tailly, Camille Berquin, et al.Urologic Oncology|January 17, 2018
Metastatic burden in newly diagnosed hormone-naive metastatic prostate cancer: Comparing definitions of CHAARTED and LATITUDE trialSarah Buelens, Filip Poelaert, Bert Dhondt, et al.BMC Medical Imaging|October 7, 2024
Retrospective analysis of multiparametric MRI in predicting complete pathologic response of neo-adjuvant chemotherapy in bladder cancerDaan De Maeseneer, Pieter De Visschere, Mats Van den Broecke, et al.Cancers|February 13, 2026
Does It Make Sense to Perform Prostate Magnetic Resonance Imaging in Men with Normal PSA (<4 ng/mL)?Pieter De Visschere, Camille Berquin, Pieter De Backer, et al.European Urology Open Science|August 2, 2021
The Role of Cytoreductive Radical Prostatectomy in the Treatment of Newly Diagnosed Low-volume Metastatic Prostate Cancer. Results from the Local Treatment of Metastatic Prostate Cancer (LoMP) RegistryNicolaas Lumen, Elise De Bleser, Sarah Buelens, et al.Histopathology|September 1, 2018
Dichotomous histopathological assessment of ductal carcinoma in situ of the breast results in substantial interobserver concordanceMieke Van Bockstal, Marcella Baldewijns, Cécile Colpaert, et al.Cancer Research|June 23, 2023
Whole Slide Imaging-Based Prediction of TP53 Mutations Identifies an Aggressive Disease Phenotype in Prostate CancerMarija Pizurica, Maarten Larmuseau, Kim Van der Eecken, et al.Journal of Translational Medicine|July 1, 2017
A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma: evaluation of safety and clinical and immunologic responseNora Sundahl, Katrien De Wolf, Sylvie Rottey, et al.European Urology Oncology|November 21, 2021
Tissue- and Blood-derived Genomic Biomarkers for Metastatic Hormone-sensitive Prostate Cancer: A Systematic ReviewKim Van der Eecken, Jan Vanwelkenhuyzen, Matthew P Deek, et al.European Urology Focus|February 19, 2025
Adjuvant Radiotherapy After Radical Cystectomy for Muscle-invasive Bladder Cancer: A Phase 2 Trial-Results of Secondary EndpointsFlor Verghote, Elke Rammant, Piet Dirix, et al.Pageof 4